Cargando…
SAT-686 Type 1 Diabetes Diagnosed in an 83 Year Old Man After Nivolumab Therapy
BACKGROUND Immune checkpoint inhibitors are increasingly being used for a variety of cancers and are a promising treatment option. Immune related adverse effects are their major side effects, most common being hypophysitis and hypothyroidism. While diabetes and adrenalitis have only been rarely repo...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7208932/ http://dx.doi.org/10.1210/jendso/bvaa046.467 |